Citigroup Adjusts Price Target on Healthpeak Properties to $20 From $18
J.P. Morgan Sticks to Their Hold Rating for Healthpeak Properties (DOC)
Scotiabank Maintains Sector Outperform on Healthpeak Properties, Raises Price Target to $23
Healthpeak Properties Analyst Ratings
JPMorgan Adjusts Price Target on Healthpeak Properties to $21 From $19, Keeps Neutral Rating
Argus Research Keeps Their Buy Rating on Healthpeak Properties (DOC)
Healthpeak Properties Analyst Ratings
BNP Paribas Adjusts Price Target on Healthpeak Properties to $21 From $19
Buy Rating Affirmed for Healthpeak Properties Amid Strong Q1 Performance and Raised Financial Guidance
Healthpeak Properties Analyst Ratings
Healthpeak Properties Analyst Ratings
Analysts Offer Insights on Real Estate Companies: Healthpeak Properties (DOC) and CoStar Group (CSGP)
Scotiabank Keeps Their Buy Rating on Healthpeak Properties (DOC)
Healthpeak Properties Gets Double-upgrade at BofA on NOI Growth Prospects
Healthpeak Properties Analyst Ratings
Healthpeak Properties Analyst Ratings
Analysts Offer Insights on Real Estate Companies: Healthpeak Properties (DOC), Uniti Group (UNIT) and CoStar Group (CSGP)
Analysts' Top Real Estate Picks: Simon Property (SPG), Healthpeak Properties (DOC)
Healthpeak Properties Analyst Ratings
Healthpeak Properties Analyst Ratings